FLT3 and acute myeloid leukemia: Interestingly, we found patients with low PCDH17 expression harboring FLT3-ITD and NPM1 mutations (the two most common mutations in CN-AML) more often than those with PCDH17 high expression; GSEA analysis further confirmed this observation.